Nurix Therapeutics, Inc. - Common stock (NRIX) stock analysis
NRIX · Nurix Therapeutics, Inc. - Common stock
Latest recorded price: USD 14.73
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 29.5%, free cash flow margin -313.7%. The model flags 1 risk signal for this company (1 high severity).